AgeneBio Founder Dr. Michela Gallagher participates in the 2018 Milken Global Conference

Gallagher highlights the groundbreaking clinical trial, HOPE4MCI, which could slow progression from Mild Cognitive Impairment to Alzheimer’s dementia LOS ANGELES, April 30, 2018 — Today, AgeneBio Founder Dr. Michela Gallagher participated in a panel discussion at the Milken Global Conference Alzheimer’s Disease: Rewriting the Playbook. The panel, hosted by Milken’s LaTese Briggs and including Todd Rainwater of the Rainwater Charitable Foundation, Lauren Miller Rogan of Hilarity…

Milken Global Conference 2018

AgeneBio Founder Michela Gallagher, PhD, will speak on “Alzheimer’s Disease: Rewriting the Playbook” on Monday, April 30, 2018, at 2:30 pm. The conference will be held at the Beverly Hilton in Beverly Hills, CA.